Detail akcie Omnicell Inc online

Business Summary: Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Omnicell Inc revenues decreased 11% to $1.15B. Net loss totaled $20.4M vs. income of $5.6M. Revenues reflect Connected devices, software licenses, and other segment decrease of 25% to $623.6M, United States segment decrease of 13% to $1.01B. Net loss reflects Impairment of Fixed Assets increase of 6% to $10M (expense), Restructuring Charges & Provisions increase of 6% to $3.8M (expense).